India, March 4 -- image credit- shutterstock

Ahmedabad-based Zydus Lifesciences has announced its focus on the development of a combination vaccine against shigellosis and typhoid.This combination vaccine, being developed for the first time in the world, underscores India's innovation capabilities with the potential to provide protection against deadly enteric diseases - Typhoid and Shigella.

Zydus will carry out early-stage development, animal immunogenicity studies and regulatory preclinical toxicology studies for this combination vaccine.The project is expected to get underway in March 2025, and is being supported by the Gates Foundation.

Zydus will collaborate with a partner for the research and co-development of a combination vacc...